Fuse Medical, Inc.
FZMD
$0.0999
$0.037961.13%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 234.68% | -106.42% | 37,962.77% | 97.09% | 32.22% |
| Total Depreciation and Amortization | -2.10% | 137.61% | -208.03% | 138.95% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -7.05% | 108.91% | -5,376.74% | 134.80% | -141.41% |
| Change in Net Operating Assets | -352.03% | 118.94% | -2,189.12% | -65.86% | -64.25% |
| Cash from Operations | -129.97% | 139.81% | -525.54% | 179.37% | -149.83% |
| Capital Expenditure | -- | -- | 632.52% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 632.52% | 65.58% | -104.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 152.88% | -463.79% | 76.26% | -161.06% | 162.44% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 152.88% | -463.79% | 75.72% | -159.69% | 162.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -32.81% | 117.62% | -265.41% | -220.25% | 365.47% |